AGP Executive Report
Last update: 4 hours agoBig Pharma Deal: Jiangsu Hengrui and Bristol Myers Squibb signed global collaboration and licensing deals worth up to $15.2 billion, covering 13 early-stage cancer and blood-disease programmes; BMS gets worldwide rights outside mainland China, Hong Kong and Macau, while Hengrui takes exclusive rights in those markets. AI in Everyday Life: China’s rapid AI adoption is moving from hype to mass use, with people lining up for help setting up AI “agents” on their laptops—showing how quickly tools are becoming workplace and daily-life infrastructure. Macau Health & Prevention: Macau launched a shared mosquito repellent scheme at 12 “Health Fuel Stations” in parks and rest areas, alongside a two-week push to eliminate stagnant water to curb dengue and chikungunya. Local Governance: Chief Executive Sam Hou Fai urged Macau’s community organisations to strengthen grassroots governance, expand social services for vulnerable groups, and support law-based governance. SME Trade Push: Guangdong-Macao Branded Products Fair exhibitor recruitment opened for the “Macao Featured Products Zone,” with applications due May 26. Oncology Updates: Erasca reported Q1 2026 business and finances, highlighting progress in its RAS-targeted pipeline.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result.
Perspectify News
